Literature DB >> 3280944

Infections after liver transplantation. An analysis of 101 consecutive cases.

S Kusne1, J S Dummer, N Singh, S Iwatsuki, L Makowka, C Esquivel, A G Tzakis, T E Starzl, M Ho.   

Abstract

We studied infections in 101 consecutive patients who underwent liver transplantation between July 1984 and September 1985. The mean length of follow-up was 394 days. Eighty-three percent of population had 1 or more episodes of infection and 67% of the population had severe infections. The overall mortality was 26/101 (26%) and 23 of 26 deaths (88%) were associated with infection. Seventy percent of severe infections occurred in the first 2 months after transplantation. The most frequent severe infections were abdominal abscess, bacterial pneumonia, invasive candidiasis, Pneumocystis pneumonia, and symptomatic cytomegalovirus infection. Patients with more than 12 hours of cumulative surgical time had a higher rate of severe infections (P less than 0.001), particularly fungal (P less than 0.001) and bacterial (P less than 0.01) infections. Also, the use of choledocho-jejunostomy was associated with a higher rate of infection in patients who had more than 1 transplant operation (P less than 0.02). No increase in infection was found in patients who received azathioprine, or more than the median number of steroid boluses or "recycles"; but patients who received OKT3 therapy had a higher rate of protozoal infections (P less than 0.05). A result similar to that of our previous studies was a strong relation between the number of severe fungal infections and prolonged courses of antibiotics after transplant operation (P less than 0.001). Pretransplant manifestations of severe liver disease such as ascites, encephalopathy, and gastrointestinal bleeding were not associated with higher rates of infection after transplantation, but high serum levels of ALT were. Patients with lower ratios of T-helper to T-suppressor lymphocytes had more severe viral (P less than 0.02) and fungal (P less than 0.01) infections after transplantation.

Entities:  

Mesh:

Year:  1988        PMID: 3280944      PMCID: PMC2979316          DOI: 10.1097/00005792-198803000-00006

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  25 in total

1.  Incidence of wound infection on the surgical services.

Authors:  P J Cruse
Journal:  Surg Clin North Am       Date:  1975-12       Impact factor: 2.741

2.  Infections in recipients of liver homografts.

Authors:  V A Fulginiti; R Scribner; C G Groth; C W Putnam; L Brettschneider; S Gilbert; K A Porter; T E Starzl
Journal:  N Engl J Med       Date:  1968-09-19       Impact factor: 91.245

3.  A five-year prospective study of 23,649 surgical wounds.

Authors:  P J Cruse; R Foord
Journal:  Arch Surg       Date:  1973-08

4.  Self-limited Toxoplasma parasitemia after liver transplantation.

Authors:  S Kusne; J S Dummer; M Ho; T Whiteside; B S Rabin; L Makowka; C O Esquivel; T E Starzl
Journal:  Transplantation       Date:  1987-09       Impact factor: 4.939

5.  Orthotopic liver transplantation in ninety-three patients.

Authors:  T E Starzl; K A Porter; C W Putnam; G P Schroter; C G Halgrimson; R Weil; M Hoelscher; H A Reid
Journal:  Surg Gynecol Obstet       Date:  1976-04

6.  Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era.

Authors:  A G Tzakis; R D Gordon; B W Shaw; S Iwatsuki; T E Starzl
Journal:  Transplantation       Date:  1985-12       Impact factor: 4.939

7.  Biliary tract complications in human orthotopic liver transplantation.

Authors:  J Lerut; R D Gordon; S Iwatsuki; C O Esquivel; S Todo; A Tzakis; T E Starzl
Journal:  Transplantation       Date:  1987-01       Impact factor: 4.939

8.  Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids.

Authors:  J M Hofflin; I Potasman; J C Baldwin; P E Oyer; E B Stinson; J S Remington
Journal:  Ann Intern Med       Date:  1987-02       Impact factor: 25.391

Review 9.  Liver transplantation today.

Authors:  R W Busuttil; L I Goldstein; G M Danovitch; M E Ament; L D Memsic
Journal:  Ann Intern Med       Date:  1986-03       Impact factor: 25.391

Review 10.  Rapid diagnosis of candidiasis and aspergillosis.

Authors:  J E Bennett
Journal:  Rev Infect Dis       Date:  1987 Mar-Apr
View more
  85 in total

Review 1.  Antifungal prophylaxis during neutropenia and immunodeficiency.

Authors:  O Lortholary; B Dupont
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Infections during a randomized trial comparing cyclosporine to FK 506 immunosuppression in liver transplantation.

Authors:  S Kusne; J Fung; M Alessiani; M Martin; J Torre-Cisneros; W Irish; L Ondick; A Jain; K Abu-Elmagd; S Takaya
Journal:  Transplant Proc       Date:  1992-02       Impact factor: 1.066

3.  Infections after liver transplantation: risk factors and prevention.

Authors:  M Martin; S Kusne; M Alessiani; R Simmons; T E Starzl
Journal:  Transplant Proc       Date:  1991-06       Impact factor: 1.066

Review 4.  Bloodstream infections after solid-organ transplantation.

Authors:  Antonios Kritikos; Oriol Manuel
Journal:  Virulence       Date:  2016-01-14       Impact factor: 5.882

Review 5.  Liver transplantation. A primer for practicing gastroenterologists, Part I.

Authors:  V J Dindzans; R R Schade; J S Gavaler; R E Tarter; D H Van Thiel
Journal:  Dig Dis Sci       Date:  1989-01       Impact factor: 3.199

Review 6.  Liver transplantation. A primer for practicing gastroenterologists. Part II.

Authors:  V J Dindzans; R R Schade; J S Gavaler; R E Tarter; D H Van Thiel
Journal:  Dig Dis Sci       Date:  1989-02       Impact factor: 3.199

7.  Infections with FK 506 immunosuppression: preliminary results with primary therapy.

Authors:  M Alessiani; S Kusne; F M Martin; J J Fung; A Jain; S Todo; R Simmons; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

8.  CMV infection in liver transplantation under cyclosporine or FK 506 immunosuppression.

Authors:  M Alessiani; S Kusne; J J Fung; J Torre-Cisneros; A Jain; K Abu-Elmagd; S Takaya; U Cillo; M Martin; S Todo
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

9.  The clinical trial of FK 506 as primary and rescue immunosuppression in pediatric cardiac transplantation.

Authors:  J M Armitage; F J Fricker; P Del Nido; L Cipriani; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

10.  Infectious complications of pediatric liver transplantation under FK 506.

Authors:  M Green; A Tzakis; J Reyes; B Nour; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.